NSF/FDA SIR: Isolation of Cancer Stem Cells by Flow Cytometric Techniques
NSF/FDA SIR: Isolation of Cancer Stem Cells by Flow Cytometric Techniques
批准号:
1238375
负责人:
Elizabeth Raveche
金额:
$11.45万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-15 至 2013-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT #1238375RavecheThe major objective of the proposed research is to employ advanced flow-cytometry-based instrumentation to develop methods and protocols for isolating distinct subpopulations of cells. This in-depth analysis of cell characterizations using fluorescence detection to distinguish 17 or more characteristics simultaneously on individual cells and employing multiple parameters to sort these populations while maintaining the viability of the cells will advance the employment of flow cytometers in biomedical research. The isolation and identification of the cancer progenitor cell is only recently feasible because the technology has evolved such that multiple fluorochromes excited by specific wavelengths emitted from several lasers and unique detectors can sort cells based on multiple markers simultaneously. This requires stable laser lines, careful compensation controls, defined fluidics and sensitive optics and detectors. The hypothesis to be tested is that based on identifiable characteristics, the earliest cancer progenitor cell in chronic lymphocytic leukemia (CLL) can be identified.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSF/FDA SIR: Isolation of cancer stem cells and the determination of the role of microRNA in B cell differentiation by flow cytometric techniques
-
批准号:1343519
-
项目类别:Standard Grant
-
资助金额:$11.45万
-
财政年份:2013
-
负责人:Elizabeth Raveche
-
依托单位:
国内基金
海外基金
FDA上市药物库筛选鉴定靶向治疗ARID1A缺陷型结直肠癌的合成致死效应及分子机制研究
-
批准号:82373165
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:李爱民
-
依托单位:
多维互质结构FDA雷达稀疏空时距自适应处理研究
-
批准号:61771317
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2017
-
负责人:阳召成
-
依托单位:
基于FDA标记畸胎瘤细胞联合人胎盘屏障体外模型建立中药胚胎毒性评价体系的研究
-
批准号:81573740
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2015
-
负责人:宋殿荣
-
依托单位: